Janelle Renee Maravelias, DPM
Podiatry · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Maravelias’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$191,990
Medicare paid this office $191,990 for 395 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 273 | $77,933 | $86 |
| Removal of noncancer thickened skin growth, 2-4 growths | 93 | $25,832 | $85 |
| Removal of fingernails or toenails, 6 or more nails | 151 | $21,540 | $44 |
| Test or measurement for functional capacity, each 15 minutes | 210 | $12,695 | $30 |
| New patient visit (30+ min) | 107 | $10,557 | $99 |
See all 12 services
| Short return visit (20+ min) | 273 | $77,933 | $86 |
| Removal of noncancer thickened skin growth, 2-4 growths | 93 | $25,832 | $85 |
| Removal of fingernails or toenails, 6 or more nails | 151 | $21,540 | $44 |
| Test or measurement for functional capacity, each 15 minutes | 210 | $12,695 | $30 |
| New patient visit (30+ min) | 107 | $10,557 | $99 |
| Removal of noncancer thickened skin growth, 1 growth | 51 | $10,236 | $72 |
| Return visit (30+ min) | 44 | $8,196 | $122 |
| Removal of noncancer thickened skin growth, more than 4 growths | 18 | $5,050 | $90 |
| New patient visit (45+ min) | 21 | $2,772 | $132 |
| X-ray of foot, minimum of 3 views | 44 | $2,065 | $36 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,437 | $68 |
| Short return visit | 13 | $1,089 | $44 |
Procedures Medicare counted
| Removal of nail tissue | 27 | More than 62% of doctors who do this |
| Removal of tissue | 258 | More than 93% of doctors who do this |
| Removal or shaving of skin growth | 57 | More than 80% of doctors who do this |
Who their Medicare patients are
395 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 23% · Women 59% · Also on Medicaid 6% · Health risk score 1.32. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 31% · Coronary heart disease 26% · Chronic kidney disease 25% · Atrial fibrillation 21% · Depression 18% · Cancer 17% · Heart failure 16% · Dementia 11% · COPD 10% · Stroke 8%.
The office billed $736,588, Medicare allowed $257,175 and paid $191,990; for 2,820 services of 44 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 395 | 2,820 | 78 | 1.32 | $736,588 | $191,990 |
| 2023 | 337 | 1,843 | 78 | 1.29 | $494,291 | $116,968 |
| 2022 | 353 | 2,207 | 78 | 1.25 | $543,478 | $155,466 |
| 2021 | 276 | 1,330 | 78 | 1.30 | $226,259 | $85,258 |
| 2020 | 139 | 389 | 79 | 1.42 | $74,340 | $28,161 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 215 | $35,307 | $76 |
| Removal of noncancer thickened skin growth, 2-4 growths | 80 | $16,654 | $77 |
| Removal of fingernails or toenails, 6 or more nails | 146 | $15,803 | $40 |
| New patient visit (30+ min) | 92 | $8,806 | $96 |
| Removal of noncancer thickened skin growth, 1 growth | 43 | $6,441 | $66 |
| Test or measurement for functional capacity, each 15 minutes | 97 | $5,386 | $28 |
| Return visit (30+ min) | 24 | $5,070 | $118 |
| Removal of noncancer thickened skin growth, more than 4 growths | 16 | $3,882 | $81 |
| Short return visit | 48 | $3,646 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,602 | $70 |
| X-ray of foot, minimum of 3 views | 24 | $1,328 | $35 |
2022: 11 services
| Short return visit (20+ min) | 200 | $41,892 | $79 |
| Removal of fingernails or toenails, 6 or more nails | 169 | $22,839 | $40 |
| Removal of noncancer thickened skin growth, 2-4 growths | 99 | $21,033 | $77 |
| New patient visit (30+ min) | 126 | $11,983 | $95 |
| Removal of noncancer thickened skin growth, 1 growth | 73 | $11,851 | $70 |
| Short return visit | 75 | $7,776 | $51 |
| Return visit (30+ min) | 35 | $6,813 | $108 |
| Removal of noncancer thickened skin growth, more than 4 growths | 22 | $5,672 | $86 |
| New patient visit (45+ min) | 15 | $2,327 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,453 | $63 |
| X-ray of foot, minimum of 3 views | 31 | $1,430 | $35 |
2021: 8 services
| Removal of fingernails or toenails, 6 or more nails | 157 | $19,606 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 75 | $15,457 | $77 |
| Short return visit (20+ min) | 73 | $11,201 | $81 |
| New patient visit (30+ min) | 116 | $9,868 | $85 |
| Removal of noncancer thickened skin growth, 1 growth | 67 | $9,566 | $64 |
| Removal of noncancer thickened skin growth, more than 4 growths | 20 | $4,485 | $86 |
| New patient visit (45+ min) | 17 | $2,665 | $157 |
| X-ray of foot, minimum of 3 views | 17 | $779 | $35 |
2020: 5 services
| New patient visit (30+ min) | 135 | $13,832 | $102 |
| Removal of fingernails or toenails, 6 or more nails | 102 | $5,219 | $44 |
| Removal of noncancer thickened skin growth, 2-4 growths | 43 | $3,702 | $76 |
| Removal of noncancer thickened skin growth, 1 growth | 27 | $2,239 | $64 |
| Short return visit (20+ min) | 12 | $933 | $72 |
Drugs they prescribed that Part D paid
$3,064
Pharmacies billed $3,064 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 151) in 2024. At or below the middle of the specialty; the typical podiatry clinician is at 5%.
148 generic and fewer than 11 brand-name prescriptions · $3,064 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciclopirox | 27 | $778 | $22 |
| Terbinafine | 16 | $338 | $8 |
| Meloxicam | 18 | $77 | $2 |
Year by year
| 2024 | 151 | 74 | 0% (0) | None | $3,064 |
| 2023 | 63 | 43 | None | 0% | $1,081 |
| 2022 | 123 | 65 | None | None | $12,329 |
| 2021 | 76 | 35 | None | None | $10,508 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Ciclopirox | 28 | $789 | $28 |
| Meloxicam | 18 | $107 | $6 |
2022: 2 drugs
| Ciclopirox | 72 | $2,596 | $36 |
| Meloxicam | 22 | $72 | $3 |
2021: 2 drugs
| Ciclopirox | 35 | $1,742 | $50 |
| Ciclopirox | 12 | $337 | $28 |
Money from drug and device companies
$203 in 2025
| 2025 | 3 | 3 | None | $203 |
| 2024 | 3 | 4 | None | $477 |
| 2023 | 6 | 7 | None | $455 |
| 2022 | 6 | 7 | None | $280 |
| 2021 | 3 | 4 | None | $192 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Organogenesis | Puraply Wound Matrix | $148 | 1 payment
|
| Treace Medical Concepts | None | $34 | 1 payment
|
| Orthofix Medical | Physio-Stim | $21 | 1 payment
|
See all 3 published payments
| Organogenesis | Meals · 2025-09-16 | Puraply Wound Matrix | $148 |
| Orthofix Medical | Meals · 2025-06-17 | Physio-Stim | $21 |
| Treace Medical Concepts | Meals · 2025-01-07 | None | $34 |
See earlier years (2024, 2023, 2022, 2021)
2024: $477
| Alafair Biosciences | Versawrap | $275 | 2 payments
|
| Stryker | Prostep Mica | $128 | 1 payment
|
| Integra LifeSciences | Integra | $74 | 1 payment
|
2023: $455
| Treace Medical Concepts | Lapiplasty System | $190 | 2 payments
|
| Smith+Nephew | Pico | $146 | 1 payment
|
| Paragon 28 | Gorilla | $43 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $37 | 1 payment
|
| ConvaTec | Aquacel Foam | $21 | 1 payment
|
| Stryker | Ortholoc 2 Lapifuse | $18 | 1 payment
|
2022: $280
| Paragon 28 | Paratrooper | $96 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System | $80 | 2 payments
|
| Nevro | Omnia | $33 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $26 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $24 | 1 payment
|
| Evolution Surgical | None | $22 | 1 payment
|
2021: $192
| Paragon 28 | Gorilla Plating System | $100 | 1 payment
|
| Smith+Nephew | Grafix Pl | $69 | 2 payments
|
| Organogenesis | Puraply Antimicrobial | $24 | 1 payment
|
Checkups this office reported
11 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 78.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 85%That's most of the people this applied to. | 455 |
| Checked for fall riskOlder patients screened for fall risk | 35%That's less than half. | 363 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 30% | 37 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 76%That's most of the people this applied to. Worse on this measure. | 37 |
| Medications listed in the chartVisits where the current medication list was documented | 21%That's few of the people this applied to. | 1,599 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 78%That's most of the people this applied to. | 890 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 97%That's most of the people this applied to. | 231 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 375 |
See the other 3 measures
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 0% | 1,480 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 76%That's most of the people this applied to. | 50 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 50%That's more than half. | 758 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Measurement and improvement at the practice and panel level
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from e-prescribing
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1962937847
- Licence
- CA E5670
- Trained
- California School of Podiatric Medicine, 2017
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 901 Campus Dr Ste 111, Daly City, CA, 94015
- NPI first listed
- 2017-04-27
- NPI last updated
- 2025-02-01
- NPI record certified
- 2025-01-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.